Izanne Roos

872 total citations
28 papers, 179 citations indexed

About

Izanne Roos is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Izanne Roos has authored 28 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Izanne Roos's work include Multiple Sclerosis Research Studies (15 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer-related cognitive impairment studies (3 papers). Izanne Roos is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer-related cognitive impairment studies (3 papers). Izanne Roos collaborates with scholars based in Australia, South Africa and Canada. Izanne Roos's co-authors include Tomáš Kalinčík, Ahmed Iqbal Bhigjee, Suzaan Marais, Vinod Patel, Charles B. Malpas, Mark Marriott, Ai‐Lan Nguyen, Sifat Sharmin, Vivien Li and Mastura Monif and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Brain.

In The Last Decade

Izanne Roos

25 papers receiving 178 citations

Peers

Izanne Roos

PFM

NEURO

ONCOL

SURGE

Ferdinand Otto Austria

Stella Hughes United Kingdom

Kathryn Connelly Australia

Hosein Nouri Iran

Elizabeth Guardiani United States

Jacqueline S. Gofshteyn United States

Behzad Amoozgar United States

Behnaz Moradi Iran

Gautier Bréville Switzerland

Michael Guger Austria

Ferdinand Otto Austria

Izanne Roos

33 ×0.5

PFM

53 ×1.5

NEURO

29 ×0.9

ONCOL

29 ×0.9

SURGE

34 ×1.1

Citations per year, relative to Izanne Roos Izanne Roos (= 1×) peers Ferdinand Otto

Countries citing papers authored by Izanne Roos

Since Specialization

Citations

This map shows the geographic impact of Izanne Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izanne Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izanne Roos more than expected).

Fields of papers citing papers by Izanne Roos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izanne Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izanne Roos. The network helps show where Izanne Roos may publish in the future.

Co-authorship network of co-authors of Izanne Roos

This figure shows the co-authorship network connecting the top 25 collaborators of Izanne Roos. A scholar is included among the top collaborators of Izanne Roos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izanne Roos. Izanne Roos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Müller, Jannis, Sifat Sharmin, Olga Skibina, et al.. (2025). CS7 Treatment de-escalation in relapsing remitting multiple sclerosis — an observational study. A6.2–A6.

Müller, Jannis, Izanne Roos, Tomáš Kalinčík, et al.. (2024). Escalating to medium‐ versus high‐efficacy disease modifying therapy after low‐efficacy treatment in relapsing remitting multiple sclerosis. Brain and Behavior. 14(5). e3498–e3498. 2 indexed citations

Signori, Alessio, Marta Ponzano, Tomáš Kalinčík, et al.. (2024). Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry. Journal of Neurology Neurosurgery & Psychiatry. 95(7). 620–625. 2 indexed citations

Sales, Carmela, Izanne Roos, Samantha M. Loi, et al.. (2024). Cognitive and Psychological Recovery from the Immune Effector Cell Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. Blood. 144(Supplement 1). 7240–7240. 1 indexed citations

Kalinčík, Tomáš, Sifat Sharmin, Izanne Roos, et al.. (2024). Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 95(8). 775–783. 5 indexed citations

Roos, Izanne, Sifat Sharmin, Charles B. Malpas, et al.. (2024). 3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. SHILAP Revista de lepidopterología. A43.1–A43.

Sales, Carmela, Izanne Roos, Samantha M. Loi, et al.. (2024). Neuropsychological outcomes of patients with haematological malignancies undergoing chimeric antigen receptor T-cell therapy: protocol for a prospective study. BMJ Neurology Open. 6(2). e000800–e000800. 2 indexed citations

Roos, Izanne, et al.. (2023). Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis. Neurologic Clinics. 42(1). 203–227. 8 indexed citations

Kalinčík, Tomáš, Izanne Roos, Sifat Sharmin, & Charles B. Malpas. (2023). Methodological considerations for observational studies of treatment effectiveness in neurology: a clinician’s guide. Journal of Neurology Neurosurgery & Psychiatry. 95(5). jnnp–2022. 1 indexed citations

10.

Kalinčík, Tomáš, Izanne Roos, & Sifat Sharmin. (2023). Observational studies of treatment effectiveness in neurology. Brain. 146(12). 4799–4808. 2 indexed citations

11.

Li, Vivien, Izanne Roos, Mastura Monif, et al.. (2022). Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 63. 103913–103913. 9 indexed citations

12.

Malpas, Charles B., Izanne Roos, Sifat Sharmin, et al.. (2022). Multiple Sclerosis Relapses Following Cessation of Fingolimod. Clinical Drug Investigation. 42(4). 355–364. 9 indexed citations

13.

Frascoli, Federico, Izanne Roos, Charles B. Malpas, & Tomáš Kalinčík. (2022). The dynamics of relapses during treatment switch in relapsing-remitting multiple sclerosis. Journal of Theoretical Biology. 541. 111091–111091. 4 indexed citations

14.

Sharmin, Sifat, Vivien Li, Ai‐Lan Nguyen, et al.. (2021). Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study. CNS Drugs. 35(8). 907–918. 30 indexed citations

15.

Li, Vivien, Ai‐Lan Nguyen, Izanne Roos, et al.. (2020). Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia. Multiple Sclerosis and Related Disorders. 46. 102516–102516. 8 indexed citations

16.

Rayner, Genevieve, Tomáš Kalinčík, Izanne Roos, et al.. (2019). Distinct psychopathology profiles in patients with epileptic seizures compared to non-epileptic psychogenic seizures. Epilepsy Research. 158. 106234–106234. 14 indexed citations

17.

Rayner, Genevieve, Tomáš Kalinčík, Izanne Roos, et al.. (2019). Personality profiles differ between patients with epileptic seizures and patients with psychogenic non-epileptic seizures. Seizure. 73. 1–8. 7 indexed citations

18.

Marais, Suzaan, et al.. (2018). Posttubercular syringomyelia in HIV-infected patients: A report of 10 cases and literature review. Journal of the Neurological Sciences. 395. 54–61. 3 indexed citations

19.

Roos, Izanne & Ahmed Iqbal Bhigjee. (2017). Autoimmune encephalitis: a missed diagnostic and therapeutic opportunity. 36(2). 66–79. 3 indexed citations

20.

Bhigjee, Ahmed Iqbal, et al.. (2017). The neuromyelitis optica presentation and the aquaporin-4 antibody in HIV-seropositive and seronegative patients in KwaZulu-Natal, South Africa. Southern African Journal of HIV Medicine. 18(1). 684–684. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact